154 related articles for article (PubMed ID: 27252739)
21. A novel immunoassay for the determination of tartrate-resistant acid phosphatase 5b from rat serum.
Alatalo SL; Peng Z; Janckila AJ; Kaija H; Vihko P; Vaananen HK; Halleen JM
J Bone Miner Res; 2003 Jan; 18(1):134-9. PubMed ID: 12510815
[TBL] [Abstract][Full Text] [Related]
22. Analytical evaluation of the Nittobo Medical tartrate resistant acid phosphatase isoform 5b (TRACP-5b) EIA and comparison with IDS iSYS in different clinically defined populations.
Cavalier E; Lukas P; Delanaye P
Clin Chem Lab Med; 2022 Feb; 60(3):394-400. PubMed ID: 34907694
[TBL] [Abstract][Full Text] [Related]
23. Tartrate-resistant acid phosphatase 5b as serum marker of bone metabolism in cancer patients.
Mose S; Menzel C; Kurth AA; Obert K; Breidert I; Borowsky K; Böttcher HD
Anticancer Res; 2003; 23(3C):2783-8. PubMed ID: 12926113
[TBL] [Abstract][Full Text] [Related]
24. Change in tartrate-resistant acid phosphatase isoform 5b levels, a marker of bone metabolism, in patients with chronic hepatitis B treated with tenofovir alafenamide.
Okamura T; Ichikawa T; Miyaaki H; Miuma S; Motoyoshi Y; Yamashima M; Yamamichi S; Koike M; Nakano Y; Honda T; Yajima H; Miyazaki O; Kuribayashi Y; Ikeda T; Taura N; Nakao K
Biomed Rep; 2022 Jan; 16(1):6. PubMed ID: 34900255
[TBL] [Abstract][Full Text] [Related]
25. High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay.
Wu ZQ; Zhang Y; Xie E; Song WJ; Yang RX; Yan CJ; Zhang BF; Xu HG
PLoS One; 2016; 11(1):e0147554. PubMed ID: 26800211
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of bisphosphonate combined with activated vitamin D in patients with aromatase inhibitor-induced osteoporosis after breast cancer operation.
Tanaka M; Itoh S; Takeuchi Y
Osteoporos Sarcopenia; 2018 Sep; 4(3):102-108. PubMed ID: 30775551
[TBL] [Abstract][Full Text] [Related]
27. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density.
Halleen JM; Ylipahkala H; Alatalo SL; Janckila AJ; Heikkinen JE; Suominen H; Cheng S; Väänänen HK
Calcif Tissue Int; 2002 Jul; 71(1):20-5. PubMed ID: 12073156
[TBL] [Abstract][Full Text] [Related]
28. Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model.
Rissanen JP; Suominen MI; Peng Z; Halleen JM
Calcif Tissue Int; 2008 Feb; 82(2):108-15. PubMed ID: 18084692
[TBL] [Abstract][Full Text] [Related]
29. Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer.
Salminen E; Ala-Houhala M; Korpela J; Varpula M; Tiitinen SL; Halleen JM; Väänänen HK
Acta Oncol; 2005; 44(7):742-7. PubMed ID: 16227166
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate.
Ettinger B; San Martin J; Crans G; Pavo I
J Bone Miner Res; 2004 May; 19(5):745-51. PubMed ID: 15068497
[TBL] [Abstract][Full Text] [Related]
31. Effect of eldecalcitol, an active vitamin D analog, on hip structure and biomechanical properties: 3D assessment by clinical CT.
Ito M; Nakamura T; Fukunaga M; Shiraki M; Matsumoto T
Bone; 2011 Sep; 49(3):328-34. PubMed ID: 21605716
[TBL] [Abstract][Full Text] [Related]
32. Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study Group.
Meunier PJ; Vignot E; Garnero P; Confavreux E; Paris E; Liu-Leage S; Sarkar S; Liu T; Wong M; Draper MW
Osteoporos Int; 1999; 10(4):330-6. PubMed ID: 10692984
[TBL] [Abstract][Full Text] [Related]
33. Tartrate-Resistant Acid Phosphatase 5b in Young Patients With Sickle Cell Disease and Trait Siblings: Relation to Vasculopathy and Bone Mineral Density.
Mokhtar GM; Tantawy AA; Hamed AA; Adly AA; Ismail EA; Makkeyah SM
Clin Appl Thromb Hemost; 2017 Jan; 23(1):64-71. PubMed ID: 26149452
[TBL] [Abstract][Full Text] [Related]
34. [Development for the determination of band 5b tartrate-resistant acid phosphatase activity in serum].
Uchida K; Nakanishi M; Yoh K
Rinsho Byori; 2001 Jan; 49(1):51-5. PubMed ID: 11215484
[TBL] [Abstract][Full Text] [Related]
35. Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis.
Wu YY; Janckila AJ; Ku CH; Yu CP; Yu JC; Lee SH; Liu HY; Yam LT; Chao TY
BMC Cancer; 2010 Apr; 10():158. PubMed ID: 20416078
[TBL] [Abstract][Full Text] [Related]
36. Tartrate-resistant acid phosphatase 5b is a potential biomarker for rheumatoid arthritis: a pilot study in Han Chinese.
Cheng T; Wang M; Chen Z; Eisenberg RA; Zhang Y; Zou Y; Deng Y; Wang M; Zhou L
Chin Med J (Engl); 2014; 127(16):2894-9. PubMed ID: 25131223
[TBL] [Abstract][Full Text] [Related]
37. Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity.
Janckila AJ; Takahashi K; Sun SZ; Yam LT
Clin Chem; 2001 Jan; 47(1):74-80. PubMed ID: 11148180
[TBL] [Abstract][Full Text] [Related]
38. Effect of raloxifene on serum triglycerides in postmenopausal women: influence of predisposing factors for hypertriglyceridemia.
Mosca L; Harper K; Sarkar S; O'Gorman J; Anderson PW; Cox DA; Barrett-Connor E
Clin Ther; 2001 Sep; 23(9):1552-65. PubMed ID: 11589267
[TBL] [Abstract][Full Text] [Related]
39. A dried blood spot-based method to measure levels of tartrate-resistant acid phosphatase 5b (TRACP-5b), a marker of bone resorption.
Eick GN; Devlin MJ; Cepon-Robins TJ; Kowal P; Sugiyama LS; Snodgrass JJ
Am J Hum Biol; 2019 May; 31(3):e23240. PubMed ID: 30897260
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of tartrate-resistant acid phosphatase (TRACP) 5b as bone resorption marker in irradiated bone metastases.
Mose S; Menzel C; Kurth AA; Obert K; Ramm U; Eberlein K; Boettcher HD; Pichlmeier U
Anticancer Res; 2005; 25(6C):4639-45. PubMed ID: 16334155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
